Format

Send to

Choose Destination
Eur Respir J. 2018 Aug 16;52(2). pii: 1801025. doi: 10.1183/13993003.01025-2018. Print 2018 Aug.

Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab.

Author information

1
Severe Asthma Service, Northwest Lung Centre, Wythenshawe Hospital, Manchester, UK.
PMID:
29976649
DOI:
10.1183/13993003.01025-2018
[Indexed for MEDLINE]

Conflict of interest statement

Conflict of interest: D.J. Allen reports non-financial support from Mundipharma for attendance at the ERS meeting, and speaker fees for presenting at an educational meeting sponsored by Astra Zeneca, outside the submitted work. Conflict of interest: L-J. Holmes reports personal fees for speaking at conferences from Novartis and TEVA, outside the submitted work.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center